Advancing
Peptide
Therapies
»
Press Releases
9-Nov-2009
Unigene Announces Financial Results for Third Quarter 2009
4-Nov-2009
Unigene to Release Third Quarter 2009 Results and Host Conference Call
20-Oct-2009
Unigene to Host Conference Call to Discuss Phase III Oral Calcitonin Licensing Agreement with Tarsa Therapeutics
20-Oct-2009
Unigene Licenses Phase III Oral Calcitonin Program to Tarsa Therapeutics
Concept
to
Commercialization
»
Why Unigene
»
Our Products
»
Stock Quote
»
Events
© Copyright 2005-2008 Unigene, Inc. ▪
Legal
